全文获取类型
收费全文 | 2516篇 |
免费 | 104篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 65篇 |
妇产科学 | 87篇 |
基础医学 | 185篇 |
口腔科学 | 34篇 |
临床医学 | 232篇 |
内科学 | 540篇 |
皮肤病学 | 27篇 |
神经病学 | 111篇 |
特种医学 | 366篇 |
外科学 | 294篇 |
综合类 | 14篇 |
一般理论 | 2篇 |
预防医学 | 188篇 |
眼科学 | 30篇 |
药学 | 121篇 |
中国医学 | 6篇 |
肿瘤学 | 326篇 |
出版年
2022年 | 10篇 |
2021年 | 27篇 |
2020年 | 20篇 |
2019年 | 32篇 |
2018年 | 35篇 |
2017年 | 24篇 |
2016年 | 51篇 |
2015年 | 53篇 |
2014年 | 76篇 |
2013年 | 97篇 |
2012年 | 114篇 |
2011年 | 120篇 |
2010年 | 88篇 |
2009年 | 78篇 |
2008年 | 93篇 |
2007年 | 108篇 |
2006年 | 122篇 |
2005年 | 132篇 |
2004年 | 120篇 |
2003年 | 96篇 |
2002年 | 116篇 |
2001年 | 102篇 |
2000年 | 103篇 |
1999年 | 85篇 |
1998年 | 56篇 |
1997年 | 60篇 |
1996年 | 44篇 |
1995年 | 43篇 |
1994年 | 38篇 |
1993年 | 33篇 |
1992年 | 52篇 |
1991年 | 42篇 |
1990年 | 45篇 |
1989年 | 37篇 |
1988年 | 34篇 |
1987年 | 28篇 |
1986年 | 31篇 |
1985年 | 28篇 |
1984年 | 13篇 |
1983年 | 14篇 |
1982年 | 17篇 |
1981年 | 11篇 |
1980年 | 12篇 |
1979年 | 14篇 |
1976年 | 7篇 |
1975年 | 10篇 |
1973年 | 12篇 |
1971年 | 10篇 |
1967年 | 6篇 |
1966年 | 8篇 |
排序方式: 共有2653条查询结果,搜索用时 31 毫秒
1.
C. Banella M. Ginevrino G. Catalano E. Fabiani G. Falconi M. Divona P. Curzi P. Panetta M.T. Voso N.I. Noguera 《Hematology/oncology and stem cell therapy》2021,14(2):163-168
FGFR–TACC, found in different tumor types, is characterized by the fusion of a member of fibroblast grown factor receptor (FGFR) tyrosine kinase (TK) family to a member of the transforming acidic coiled-coil (TACC) proteins. Because chromosome numerical alterations, hallmarks of FGFR–TACC fusions are present in many hematological disorders and there are no data on the prevalence, we studied a series of patients with acute myeloid leukemia and myelodysplastic syndrome who presented numerical alterations using cytogenetic traditional analysis. None of the analyzed samples showed FGFR3–TACC3 gene fusion, so screening for this mutation at diagnosis is not recommended. 相似文献
2.
3.
G B Catalano N Cavallaro P Gangemi A Garozzo G Gorgone F Spina 《Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde》1988,196(4):200-203
A rare case of basosquamous carcinoma of the orbit invading the maxillary sinus is presented. The authors discuss clinical and pathological findings. Techniques for removal and reconstructive plastic surgery are reported. 相似文献
4.
Nancy Morabito Agostino Gaudio Antonino Lasco Antonino Catalano Marco Atteritano Aldo Trifiletti Giuseppina Anastasi Darwin Melloni Nicola Frisina 《Journal of bone and mineral research》2004,19(11):1766-1770
Today, androgen deprivation therapy is a cornerstone of treatment for advanced prostate cancer, although it presents important complications such as osteoporosis. Neridronate, a relatively new bisphosphonate, is able to prevent bone loss in patients with prostate cancer during androgen ablation. INTRODUCTION: Androgen-deprivation therapy (ADT) is a cornerstone of treatment for advanced prostate cancer. This therapy has iatrogenic complications, such as osteoporosis. The aim of our study was to evaluate the efficacy of neridronate, a relatively new bisphosphonate, to prevent bone loss during androgen ablation. MATERIALS AND METHODS: Forty-eight osteoporotic patients with prostate cancer, treated with 3-month depot triptorelina, were enrolled and randomly assigned to two different treatment groups: group A (n = 24) was treated with a daily calcium and cholecalciferol supplement (500 mg of elemental calcium and 400 IU cholecalciferol), and group B (n = 24) received in addition to the same daily calcium and cholecalciferol supplement, 25 mg of neridronate given intramuscularly every month. All patients also received bicalutamide for 4 weeks. Lumbar and femoral BMD was evaluated by DXA at baseline and after 1 year of therapy; moreover, deoxypyridinoline (DPD) and bone alkaline phosphatase (BALP) were determined at the beginning, midway through, and at the end of the study. RESULTS: After 6 and 12 months, whereas patients treated only with calcium and cholecalciferol (group A) showed a marked bone loss, with increased levels of DPD and BALP compared with baseline values, patients treated also with neridronate (group B) had substantially unchanged levels of these markers. After 1 year of treatment, lumbar and total hip BMD decreased significantly in patients treated only with calcium and cholecalciferol (group A), whereas it did not change significantly at any skeletal site in patients treated also with neridronate (group B). No relevant side effects were recorded during our study. CONCLUSIONS: Neridronate is an effective treatment in preventing bone loss in the hip and lumbar spine in men receiving ADT for prostate cancer. 相似文献
5.
How do genes exert their role? Period 3 gene variants and possible influences on mood disorder phenotypes 总被引:1,自引:0,他引:1
Paola Artioli Cristina Lorenzi Adele Pirovano Alessandro Serretti Francesco Benedetti Marco Catalano Enrico Smeraldi 《European neuropsychopharmacology》2007,17(9):587-594
The action of multiple liability genes is responsible for complex phenotypes at the same time, a single gene, could control several phenotypic features. This is the case of human period 3 gene (hper3), mainly involved in the setting of the biologic clock. Some variants of this gene, besides being associated with the Delayed Sleep Phase Syndrome, showed a key role in determining evening preference rather than morning one. According to this rationale, we hypothesized that this gene could influence circadian mood fluctuations, in mood disorders. Our study demonstrated that rare genetic variants of hper3 are significantly associated to a number of mood disorders features, such as age of onset, response to SSRIs treatment, circadian mood oscillations and characteristics of temperament. These preliminary results could shed further light on the involvement of circadian genes in various aspects of physiological and psychopathological mechanisms of the brain. 相似文献
6.
Tracy W. Harachi Yoonsun Choi Robert D. Abbott Richard F. Catalano Siri L. Bliesner 《Prevention science》2006,7(4):359-368
While there is growing awareness for the need to examine the etiology of problem behaviors across cultural, racial, socioeconomic, and gender groups, much research tends to assume that constructs are equivalent and that the measures developed within one group equally assess constructs across groups. The meaning of constructs, however, may differ across groups or, if similar in meaning, measures developed for a given construct in one particular group may not be assessing the same construct or may not be assessing the construct in the same manner in other groups. The aims of this paper were to demonstrate a process of testing several forms of equivalence including conceptual, functional, item, and scalar using different methods. Data were from the Cross-Cultural Families Project, a study examining factors that promote the healthy development and adjustment of children among immigrant Cambodian and Vietnamese families. The process described in this paper can be implemented in other prevention studies interested in diverse groups. Demonstrating equivalence of constructs and measures prior to group comparisons is necessary in order to lend support of our interpretation of issues such as ethnic group differences and similarities. 相似文献
7.
P M Som A R Silvers P J Catalano M Brandwein A S Khorsandi 《AJNR. American journal of neuroradiology》1997,18(1):173
A 62-year-old woman had proptosis of the right eye, decreased visual acuity of the left eye, and no other focal neurologic deficits. She had a grand mal seizure 1 month before admission. The CT and MR studies showed extensive bone destruction of the margins of the right orbit, the floor of the middle cranial fossa, the right cavernous sinus, and much of the calvaria. There was considerable dural disease and tumor in the right orbit, paranasal sinuses, and scalp, as well as mucoceles of the left ethmoidal sinus with desiccated secretions. The diagnosis was adenosquamous carcinoma, an aggressive tumor related to both squamous cell carcinoma and adenocarcinoma. 相似文献
8.
9.
Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience 总被引:14,自引:0,他引:14
10.
The use of different approaches to measurement in drug abuse treatment outcome studies has resulted in a lack of comparability across studies. This paper reviews different approaches to timing of baseline and follow-up periods and to dealing with time periods during which follow-up subjects are not "at risk" for drug use. Length and timing of baseline and follow-up periods are considered as well as periods of time within which specific drug use outcomes are measured. It is suggested that research focus on describing the natural course of drug use both prior to and following treatment, in order to determine the most appropriate length and timing of follow-up periods. It is recommended that investigators report drug use data from both "at risk" and "not at risk" periods, and that they choose methods of controlling for time "at risk" which do not eliminate important drug use data from analyses. 相似文献